NCT07420101 Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based Programs
| NCT ID | NCT07420101 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kimberley Roche |
| Condition | Caregiver Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2026-02-01 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
"Scanxiety" is a term coined to describe anxiety related to imaging during cancer treatment and has not been robustly studied in pediatric oncology caregivers. Mindfulness-based Stress Reduction (MBSR) is a meditation-based program that offers a non-pharmacologic approach to managing stress. The main purposes of this study are two-fold: 1). to determine if scanxiety exists in the caregivers of pediatric oncology patients and 2.) if scanxiety is found, does the implementation of a mindfulness program help to improve caregiver anxiety related to imaging.
Eligibility Criteria
Inclusion Criteria: * Able to understand spoken English and be able to read written English * 18 years of age or older * Able to understand and willing to sign informed consent document * Have access to a smart phone or tablet device that is able to receive texts * Is a caregiver of any age oncology patient (including patients above 18 years of age) * Caregiver of a patient that is scheduled for a routine scan (CT's, MRI's, PET scans) within the upcoming 3 months * If assigned to the Phase 2 intervention group, willing and able to eat a raisin (a box of which will be mailed to home address) Exclusion Criteria: * Oncology patient is of adult age and caring for self * Medically-diagnosed cognitive delay in caregiver (by self-disclosure in eligibility questionnaire) * Upcoming scan is due to concern for relapse/disease recurrence and is urgent * Upcoming scan is part of initial oncology work-up * Any non-routine surveillance scan
Contact & Investigator
Kimberley Roche, MSN, PPCNP-BC, APRN
PRINCIPAL INVESTIGATOR
Connecticut Children's Medical Center
Frequently Asked Questions
Who can join the NCT07420101 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Caregiver Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07420101 currently recruiting?
Yes, NCT07420101 is actively recruiting participants. Contact the research team at KRoche01@connecticutchildrens.org for enrollment information.
Where is the NCT07420101 trial being conducted?
This trial is being conducted at Hartford, United States.
Who is sponsoring the NCT07420101 clinical trial?
NCT07420101 is sponsored by Kimberley Roche. The principal investigator is Kimberley Roche, MSN, PPCNP-BC, APRN at Connecticut Children's Medical Center. The trial plans to enroll 160 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.